% | $
Quotes you view appear here for quick access.

Cadence Pharmaceuticals, AŞ Message Board

  • dragan7777777777 dragan7777777777 Jun 21, 2013 5:53 AM Flag

    Ofirmev is the winner...

    Ofirmev is the winner, no issues about this drug. In a few yrs there will be no acute pain service in any hospital without IV acetaminophen. I am still waiting to see it on this side of the border. Will never ever use IV NSAIDS ( Toradol, or others ) again. Manufacturing is not an issue anymore. Getting rid of lousy Baxter was a great move. The main issue now is generics. If CADX win the court case it will be blue sky and PPS will hit 52wks and all time high in short order. GLA.....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Have any of you expert investors ever had IV acetaminophen for acute post-operative pain relief? I have over 30 years of experience as a surgeon and most recently experience as a patient following an orthopaedic procedure.
      There is no doubt in my mind that IV acetaminophen is a superior analgesic compared to available IV opiods. With better CSF penetration pain relief with Ofirmev was almost instantaneous and lasting as long as 3 to 4 hours. IV opiods only produce instant G-I complaints and spotty pain relief with somnolence. Do not make the mistake of comparing oral acetaminophen with IV. Based on my experiences I strongly believe use of Ofirmev will increase. Also note less G-I toxicity compared to oral as IV avoids the G-I absorption and first hepatic pass.

      Sentiment: Buy

    • What is Canada doing up there with their submission----did the mounties lose ity---LOL! Come on---approve the @#$%@! its IV tylenol for cripes sakes!

      Been trading these ups and downs around a bit heavier core over the last couple of months. Nice for trading lately!



      Sentiment: Strong Buy

    • Plus, it's only a few more weeks until 2Q numbers come in. Hopefully the recent upward trend will resume!

      Sentiment: Buy

    • I agree, we are starting to see a strong pick up in usage in our hospital. Where anesthesiologist were skeptical, they are starting to see the benefits of using it. In the world of Obamacare, you will need to do more surgeries, and the only way to do that is by getting them out a lot quicker. Ofirmev delivers on all cylinders here.

    • if market is going down more , buying around 5.5 to 6 would be great